Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study
PLOS Medicine · 21.11.2023 · 20 (11) · e1004311
DOI: 10.1371/journal.pmed.1004311 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Medicine, online erschienen am 21.11.2023. Verfasst von Karl M F Emmert-Fees und 10 weiteren Autor:innen. Beteiligte Einrichtung: Professorship of Public Health and Prevention, School of Medicine and Health, Technical University of Munich, Munich, Germany. Hauptthemen laut MEDLINE: Sugar-Sweetened Beverages, Diabetes Mellitus, Type 2, Cardiovascular Diseases. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Background
Taxes on sugar-sweetened beverages (SSBs) have been implemented globally to reduce the burden of cardiometabolic diseases by disincentivizing consumption through increased prices (e.g., 1 peso/litre tax in Mexico) or incentivizing industry reformulation to reduce SSB sugar content (e.g., tiered structure of the United Kingdom [UK] Soft Drinks Industry Levy [SDIL]). In Germany, where no tax on SSBs is enacted, the health and economic impact of SSB taxation using the experience from internationally implemented tax designs has not been evaluated. The objective of this study was to estimate the health and economic impact of national SSBs taxation scenarios in Germany. Methods and findings In this modelling study, we evaluated a 20% ad valorem SSB tax with/without taxation of fruit juice (based on implemented SSB taxes and recommendations) and a tiered tax (based on the UK SDIL) in the German adult population aged 30 to 90 years from 2023 to 2043. We developed a microsimulation model (IMPACT NCD Germany) that captures the demographics, risk factor profile and epidemiology of type 2 diabetes, coronary heart disease (CHD) and stroke in the German population using the best available evidence and national data. For each scenario, we estimated changes in sugar consumption and associated weight change. Resulting cases of cardiometabolic disease prevented/postponed and related quality-adjusted life years (QALYs) and economic impacts from healthcare (medical costs) and societal (medical, patient time, and productivity costs) perspectives were estimated using national cost and health utility data. Additionally, we assessed structural uncertainty regarding direct, body mass index (BMI)-independent cardiometabolic effects of SSBs and cross-validated results with an independently developed cohort model (PRIMEtime). We found that SSB taxation could reduce sugar intake in the German adult population by 1 g/day (95%-uncertainty interval [0.05, 1.65]) for a 20% ad valorem tax on SSBs leading to reduced consumption through increased prices (pass-through of 82%) and 2.34 g/day (95%-UI [2.32, 2.36]) for a tiered tax on SSBs leading to 30% reduction in SSB sugar content via reformulation. Through reductions in obesity, type 2 diabetes, and cardiovascular disease (CVD), 106,000 (95%-UI [57,200, 153,200]) QALYs could be gained with a 20% ad valorem tax and 192,300 (95%-UI [130,100, 254,200]) QALYs with a tiered tax. Respectively, €9.6 billion (95%-UI [4.7, 15.3]) and €16.0 billion (95%-UI [8.1, 25.5]) costs could be saved from a societal perspective over 20 years. Impacts of the 20% ad valorem tax were larger when additionally taxing fruit juice (252,400 QALYs gained, 95%-UI [176,700, 325,800]; €11.8 billion costs saved, 95%-UI [€6.7, €17.9]), but impacts of all scenarios were reduced when excluding direct health effects of SSBs. Cross-validation with PRIMEtime showed similar results. Limitations include remaining uncertainties in the economic and epidemiological evidence and a lack of product-level data.
Conclusions
In this study, we found that SSB taxation in Germany could help to reduce the national burden of noncommunicable diseases and save a substantial amount of societal costs. A tiered tax designed to incentivize reformulation of SSBs towards less sugar might have a larger population-level health and economic impact than an ad valorem tax that incentivizes consumer behaviour change only through increased prices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Professorship of Public Health and Prevention, School of Medicine and Health, Technical University of Munich, Munich, Germany.
- Institute for Medical Information Processing, Biometry, and Epidemiology, Pettenkofer School of Public Health LMU Munich, Munich, Germany.
- Institute of Epidemiology, Helmholtz Zentrum München, Research Center for Environmental Health, Neuherberg, Germany.
- Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.
- Oxford Health Biomedical Research Centre, National Institute of Health and Care Research, Oxford, United Kingdom.
- Epidemiology, University of Augsburg, University Hospital Augsburg, Augsburg, Germany.
ORCID-Profile: Karl M F Emmert-Fees, Ben Amies-Cull, Jakob Linseisen, Annette Peters, Linda J Cobiac, Martin O'Flaherty, Peter Scarborough, Chris Kypridemos
Förderung
- Deutsches Forschungszentrum für Gesundheit und Umwelt, Helmholtz Zentrum München
- Bundesministerium für Bildung und Forschung
Zitieren
APA
Emmert-Fees, K. M. F., Amies-Cull, B., Wawro, N., Linseisen, J., Staudigel, M., Peters, A., Cobiac, L. J., O'Flaherty, M., Scarborough, P., Kypridemos, C., & Laxy, M. (2023). Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study. PLOS Medicine, 20(11), e1004311. https://doi.org/10.1371/journal.pmed.1004311
Vancouver
Emmert-Fees KMF, Amies-Cull B, Wawro N, Linseisen J, Staudigel M, Peters A, et al. Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study. PLOS Medicine. 2023;20(11):e1004311. doi:10.1371/journal.pmed.1004311
BibTeX
@article{EmmertFees2023,
author = {Emmert-Fees, Karl M F and Amies-Cull, Ben and Wawro, Nina and Linseisen, Jakob and Staudigel, Matthias and Peters, Annette and Cobiac, Linda J and O'Flaherty, Martin and Scarborough, Peter and Kypridemos, Chris and Laxy, Michael},
title = {Projected health and economic impacts of sugar-sweetened beverage taxation in Germany: A cross-validation modelling study},
journal = {PLOS Medicine},
year = {2023},
volume = {20},
number = {11},
pages = {e1004311},
doi = {10.1371/journal.pmed.1004311}
}
EUVIMED